Product NDC: | 29033-004 |
Proprietary Name: | Carbamazepine |
Non Proprietary Name: | Carbamazepine |
Active Ingredient(s): | 300 mg/1 & nbsp; Carbamazepine |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 29033-004 |
Labeler Name: | Nostrum Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076697 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110520 |
Package NDC: | 29033-004-12 |
Package Description: | 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (29033-004-12) |
NDC Code | 29033-004-12 |
Proprietary Name | Carbamazepine |
Package Description | 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (29033-004-12) |
Product NDC | 29033-004 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Carbamazepine |
Dosage Form Name | CAPSULE, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20110520 |
Marketing Category Name | ANDA |
Labeler Name | Nostrum Laboratories, Inc. |
Substance Name | CARBAMAZEPINE |
Strength Number | 300 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC] |